Aims/Purpose: Patients with melanoma‐associated retinopathy (MAR) experience visual impairment, which can persist even following remission of the melanoma. Here we report two patients in whom symptoms improved following intravitreal dexamethasone implants.Methods: An 81 year old man reported recent onset visual disturbance. Electroretinograms (ERGs) revealed loss of ON bipolar signals, raising the possibility of MAR. Further investigation revealed metastatic melanoma. The patient underwent treatment, resulting in melanoma remission. The second patient (an 87 year old man) was diagnosed with metastatic melanoma and later developed visual symptoms in his better eye (the other eye had a prior ischaemic retinal vein occlusion). ERGs revealed selective ON bipolar signal loss, consistent with MAR. In both patients, despite systemic melanoma treatment, visual symptoms persisted.Results: The first patient underwent cycles of plasma exchange, but vision continued to deteriorate, with visual acuity reaching 20/120 and 20/600 in right and left eye respectively. In light of prior reports of intravitreal steroids improving some cases of MAR, he underwent intravitreal dexamethasone implants. This was associated with subjective improvement of symptoms as well as improved acuity. Multiple treatments were performed to both eyes, with visual acuity stabilising around 20/80 in both eyes. The second patient found his symptoms of photopsia and impaired colour vision troubling. Visual acuity dropped to 20/40. After one intravitreal dexamethasone implant, symptoms improved markedly, with acuity also improving slightly to 20/30. Both patients remain under review.Conclusions: The cases highlight the importance of considering possible paraneoplastic retinopathy in visual dysfunction and apparently unremarkable examination (in the first case, the symptoms preceded the melanoma diagnosis). The cases add to the few existing case reports of possible benefit from intravitreal steroid in MAR.ReferencesAmeerah Ilyas,1 Jit Kai Tan,1–3 Supawat Trepatchayakorn,2 Edward Bloch,1–3 Anthony G. Robson,1,4 Gordon T. Plant,5 Jonny Virgo,3 Andrew R. Webster,1,2 Carlos Pavesio,1,2 Moin D. Mohamed,3 Omar A. Mahroo1–4 UCL Institute of Ophthalmology Retinal Service, Moorfields Eye Hospital
Read full abstract